Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Change at the top at Teva as Vigodman departs

Change at the top at Teva as Vigodman departs is struggling to absorb an Actavis generics unit it bought for around $40bn last year. ... Peterburg said the "immediate focus" is "realising the cost synergies and strategic benefits of the Actavis generics acquisition".

Teva Generics Europe appoints president and CEO

Teva Generics Europe appoints president and CEO Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Deal Watch November 2016

Deal Watch November 2016 3.63. 2015. 23.30 (a). 2014. 98.63 (b). 2013. 20.98. (a) excludes $160bn Pfizer bid for Actavis/Allergan which was ultimately terminated. ... b) includes Actavis' $66bn acquisition of Allergan. But there may be some big deals in the wings.

Deal Watch October 2016

Deal Watch October 2016 In this scenario Actavis (Allergan) put at risk less than 17% of the total consideration rather than the 33% Astellas has paid. ... Teva (IS). Intas (IN). Asset Acquisition. Former Actavis generics business and factory in UK and Ireland.

Teva appoints UK & Ireland general manager

Teva appoints UK & Ireland general manager role in the company's acquisition of Actavis Generics.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...

Infographics